“Very helpful reception staff, efficient processing through the appointment, and very professional treatment.”
Central Retinal Artery Occlusion: A Retinal Emergency
Who Is at Risk?
CRAO most commonly affects adults in their 60s, and it occurs more often in men than in women. Because it shares its underlying mechanisms with stroke and heart disease, the risk factors overlap significantly with those conditions.
Several lifestyle and health factors are known to increase the risk of CRAO. Addressing these factors is one of the most effective ways to reduce the chance of a vascular event in the eye or elsewhere in the body.
- Cigarette smoking
- High blood pressure (hypertension)
- High cholesterol and elevated blood lipid levels
- Diabetes
- Elevated body mass index (obesity)
- Cardiac disease, particularly atrial fibrillation
Atrial fibrillation is an irregular heart rhythm that allows blood to pool in the heart and form clots. Those clots can then travel to the retinal artery. A CRAO diagnosis is sometimes the first sign that a person has an undiagnosed heart rhythm disorder, which is one reason a full cardiac evaluation is recommended after any retinal artery occlusion.
Certain blood disorders and inflammatory diseases also raise CRAO risk. These include polycythemia vera, multiple myeloma, factor V Leiden mutation, and elevated homocysteine levels. Conditions that affect how blood clots, known as coagulopathies, are another important category to evaluate, particularly in younger patients who do not have obvious cardiovascular risk factors.
Recognizing the Symptoms
Knowing the warning signs of CRAO can be the difference between meaningful vision recovery and permanent vision loss. The symptoms are distinctive and should always be treated as a medical emergency.
The defining symptom of CRAO is sudden, painless loss of vision in one eye. The vision loss typically develops over seconds and can be profound. The absence of pain is one of the features that can cause people to delay seeking care, but painlessness does not reduce the severity or urgency of the condition.
Some patients experience temporary vision loss before a full occlusion occurs. This is called amaurosis fugax, a brief, painless episode of vision loss in one eye that resolves on its own, usually within minutes. It can feel like a curtain or shadow passing over the eye. Amaurosis fugax should never be dismissed, as it may signal that a complete retinal artery blockage or stroke is imminent.
Anyone who experiences even a single short episode of vision loss in one eye should seek immediate medical evaluation, even if their vision returns to normal.
During examination, a Retina Specialist looks for several hallmark signs of CRAO. The retina appears diffusely pale because it is not receiving adequate blood flow. A bright red spot, called a cherry-red spot, is often visible at the center of the macula. This occurs because the thin tissue at the very center allows the underlying well-supplied layer to show through, while the surrounding swollen retina appears white by comparison.
A Retina Specialist will also test for an afferent pupillary defect, sometimes called a Marcus Gunn pupil, where the pupil in the affected eye does not respond to light normally. This finding indicates significant disruption to the visual pathway and supports the CRAO diagnosis.
Diagnosis and Evaluation
Diagnosing CRAO promptly is essential. The combination of clinical findings and focused testing helps confirm the diagnosis and guides the urgent systemic evaluation that every patient needs.
Diagnosis begins with a thorough examination by a Retina Specialist. The characteristic appearance of the retina, including the pale background and cherry-red spot, combined with the history of sudden painless vision loss, is usually sufficient to establish the diagnosis. Pupil testing confirms the degree of visual pathway involvement.
Optical coherence tomography (OCT) is a noninvasive scan that produces detailed cross-sectional images of the retinal layers. In CRAO, it can reveal swelling in the inner retina caused by the lack of blood flow. Fluorescein angiography, which uses a special dye injected into a vein to photograph blood circulation in the retina, may show delayed or absent filling of the retinal arteries. Our team uses these and other imaging tools to fully assess the extent of injury and guide management.
Because CRAO shares its causes with stroke and heart attack, a comprehensive systemic workup is a standard part of care. This typically includes imaging of the carotid arteries in the neck to check for plaque, a cardiac evaluation including an electrocardiogram and echocardiogram, and blood tests for cholesterol, blood sugar, clotting factors, and inflammatory markers.
Current medical guidelines recommend that patients with acute CRAO be referred immediately to a stroke center for evaluation. Brain imaging may also be performed to rule out an active or recent cerebral stroke occurring at the same time as the retinal event.
Treatment Approaches
CRAO requires urgent action. While no single treatment has been proven to reliably restore vision in all patients, the available options and the importance of immediate care are important to understand.
Intravenous thrombolysis is a medication given through a vein to dissolve blood clots. Current guidelines from the American Heart Association support considering this treatment in patients with nonarteritic CRAO within 4.5 hours of symptom onset, provided there are no contraindications. Clinical data suggest that some patients treated within this window experience meaningful recovery of visual function. This treatment requires immediate emergency department care and is not appropriate or available for every patient.
A number of older approaches have been used over the years, including ocular massage to attempt to dislodge the embolus, medications to lower eye pressure, and breathing techniques intended to increase carbon dioxide levels in the blood. Current evidence does not support these approaches as reliable or effective treatments, and they should not be used as substitutes for emergency care.
Even when vision cannot be restored, urgent identification and treatment of cardiovascular risk factors is a critical part of care after CRAO. Bringing high blood pressure, elevated cholesterol, diabetes, and atrial fibrillation under control reduces the risk of stroke, heart attack, and future vascular events in the remaining eye. This part of care is just as important as any direct eye treatment and should be managed in close partnership with a primary care physician or cardiologist.
Visual Outcomes and What to Expect
The prognosis for vision after CRAO depends on several factors, including how quickly treatment is sought, how long the artery was blocked, and whether a certain anatomical feature is present in the affected eye.
Unfortunately, the visual prognosis after CRAO is generally poor for most patients. The majority of people with CRAO retain only very limited vision in the affected eye, often described as counting fingers at close range or worse. The amount of permanent damage is closely tied to how long the retina was deprived of blood flow before treatment was received or the blockage resolved on its own.
About one in four people have an additional small artery called a cilioretinal artery that supplies a portion of the central retina. This artery comes from a separate blood supply and can continue to nourish part of the macula even when the main retinal artery is blocked. Patients with CRAO who have a cilioretinal artery often have a substantially better visual outcome. A Retina Specialist can identify whether this artery is present during examination and imaging.
After a CRAO event, ongoing medical follow-up is essential. Regular visits with both a Retina Specialist and a primary care or cardiovascular physician help monitor eye health and manage systemic risk factors. Patients diagnosed with atrial fibrillation may need anticoagulation therapy to prevent future clot formation. Keeping blood pressure, cholesterol, and blood sugar well controlled protects not only the remaining vision in the unaffected eye but also the health of the heart and brain.
Life After Central Retinal Artery Occlusion
Adjusting to vision changes and reducing the risk of future events are both important parts of life after a CRAO diagnosis. A thoughtful, ongoing approach to care makes a meaningful difference.
Stopping smoking, controlling blood pressure, managing cholesterol and diabetes, and maintaining a healthy weight all reduce the risk of another vascular event. If atrial fibrillation was identified as part of the workup, following a cardiologist's treatment plan closely is essential. These steps protect the brain and heart as much as they protect the eyes.
After a CRAO in one eye, the health of the other eye becomes a priority. The same risk factors that caused the first event remain a threat to the second eye. Regular examinations with a Retina Specialist allow for early detection of any changes and provide an opportunity to reassess how well vascular risk factors are being managed.
If significant vision loss occurs in one eye, a Retina Specialist or low-vision rehabilitation specialist can help develop strategies to make the most of remaining vision. Magnifying devices, adjusted lighting, and techniques for managing everyday tasks can all be helpful. The unaffected eye typically continues to function normally, which allows most people to maintain meaningful independence.
Frequently Asked Questions
The following questions address common concerns patients and families have when facing a CRAO diagnosis or sudden vision loss.
Yes, urgently. Brief episodes of temporary vision loss in one eye, known as amaurosis fugax, can resolve completely and feel harmless, but they are a recognized warning sign that a full retinal artery occlusion or cerebral stroke may be imminent. Evaluation is needed even when vision has fully returned because the window for preventing a more serious event may still be open. Do not wait to see whether another episode occurs.
A retinal artery occlusion is caused by the same mechanisms as stroke and heart attack. The condition may be the first visible sign of an underlying heart rhythm disorder, carotid artery disease, or other cardiovascular problem that has not yet been diagnosed. Treating only the eye while ignoring systemic causes leaves the patient at continued risk for stroke and other life-threatening events. A coordinated approach between ophthalmology and cardiology is the standard of care.
The presence of a cilioretinal artery cannot be determined without a professional eye examination and imaging. A Retina Specialist can identify it during a dilated fundus exam and confirm it with fluorescein angiography, which shows the pattern of blood flow in the retina. If this artery is present and supplying the central macula, the visual prognosis is often significantly better than average. This is one of the reasons a prompt, thorough evaluation by a specialist matters even after a partial or incomplete occlusion.
Intravenous thrombolysis, the clot-dissolving treatment currently supported by guidelines, is generally considered only within 4.5 hours of symptom onset because the retina sustains irreversible damage beyond that window. However, arriving after this threshold does not mean care is pointless. Comprehensive evaluation of cardiovascular risk factors, management of conditions like atrial fibrillation, and close monitoring of the unaffected eye remain critical priorities regardless of when a patient is seen. Prompt evaluation is always worthwhile.
Bilateral CRAO, affecting both eyes at the same time, is rare. However, the vascular risk factors responsible for one event continue to threaten the other eye, the brain, and the heart. Patients who have had CRAO in one eye are at elevated risk for future vascular events, including a blockage in the other eye. This is why lifelong attention to cardiovascular risk management and regular retinal examinations are strongly recommended after any retinal artery occlusion.
A retinal artery occlusion blocks blood from entering the retina, depriving it of oxygen, while a retinal vein occlusion blocks blood from draining out, causing a backup of fluid and bleeding. Both are serious retinal vascular emergencies, but they have different appearances, different treatment approaches, and somewhat different risk profiles. A Retina Specialist can distinguish between the two through examination and imaging and will guide the appropriate plan for each.
See Our Team at Atlantic Retina Center
Sudden vision loss is always a reason to seek immediate care, and our team at Atlantic Retina Center is here to provide expert evaluation and management across the Eastern Shore of Maryland and central and southern Delaware. Our fellowship-trained, board-certified Retina Specialists focus exclusively on the retina, vitreous, and macula, bringing specialized experience to conditions as complex and urgent as CRAO. We welcome referrals and are committed to delivering the high level of retinal care that patients throughout our region deserve.